Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability

Research output: Contribution to journalArticlepeer-review

22 Citations (SciVal)
154 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability'. Together they form a unique fingerprint.

Medicine & Life Sciences